Skip to content

Clinical trials

Adenocarcinoma trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Brazil Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20094
20102
20111
20152
20181
20202
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Recruiting3
Terminated2
Unknown status2
Available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.3
AstraZeneca3
Eli Lilly and Company2
Eurofarma Laboratorios S.A.2
Barretos Cancer Hospital1
Boehringer Ingelheim1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Hoffmann-La Roche1
Instituto do Cancer do Estado de São Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma21
Carcinoma7
Neoplasms6
Stomach Neoplasms6
Carcinoma, Non-Small-Cell Lung3
Esophageal Neoplasms3
Neoplasm Metastasis3
Colorectal Neoplasms2
Neoplasms by Histologic Type2
Neoplasms by Site2

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.